Skip to main content

Sigma-Aldrich Completes Proligo Acquisition

NEW YORK, April 4 (GenomeWeb News) - Sigma-Aldrich announced last week that it has completed its acquisition of DNA and RNA maker Proligo from Degussa.

 

Financial terms of the transaction were not disclosed. According to Sigma-Aldrich, Proligo had 2004 sales of about $40 million.

 

Sigma-Aldrich first announced its intent to acquire Proligo in February.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.